Literature DB >> 499275

Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.

K Karrer, W Rella, A Goldin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 499275     DOI： 10.1016/0014-2964(79)90228-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Intrapleural and intravenous Corynebacterium parvum in patients with resected stage I and II non-small cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.

Authors: 
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Monoclonal antibodies to Lewis lung carcinoma.

Authors:  S Ukei; I Saiki; I Azuma
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM).

Authors:  G Sava; T Giraldi; J Tomasić; I Hrsak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs.

Authors:  T Matsuzaki; T Yokokura; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.